A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Mayo Clinic
Beijing Biotech
Ohio State University Comprehensive Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Sumitomo Pharma America, Inc.
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Azienda Ospedaliero-Universitaria di Parma
Karyopharm Therapeutics Inc
Cancer Research UK
M.D. Anderson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Institute of Hematology & Blood Diseases Hospital, China
Senti Biosciences
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Cancer Research UK
Case Comprehensive Cancer Center
University of Iowa
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Incyte Corporation
University of Rochester
Affiliated Hospital of Qinghai University
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Asan Medical Center
Rigshospitalet, Denmark
University of Nebraska
Northwestern University
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center